Biography: Haitham Haddad, MD
Expertise
Titles
- Medical Director, Pediatric Emergency Medicine, UH Rainbow Babies and Children's Hospital
- Assistant Professor, CWRU School of Medicine
Certifications & Memberships
- Pediatrics - American Board of Pediatrics
Education
Fellowship | Neonatal-Perinatal Medicine
Neonatal-Perinatal Medicine - Metrohealth Medical Center (1993 - 1995)
Residency | Pediatrics
Pediatrics - Metrohealth Medical Center (1990 - 1993)
Medical Education
University Of Damascus Faculty Of Medicine (1987)
About
Haitham Haddad, MD, FAAP, is medical director of the Division of Pediatric Emergency Medicine and attending physician in both the Pediatric Emergency Department and Pediatric Sedation Unit at University Hospitals Rainbow Babies & Children’s Hospital. He is an assistant professor of pediatrics at Case Western Reserve University School of Medicine.
Dr. Haddad is board certified in pediatrics and certified in pediatric advanced trauma life support and pediatric advanced life support. His special interests are in pediatric emergency care, pediatric emergency department operations, and viral bronchial infections.
Dr. Haddad is a graduate of Damascus University Medical School, Damascus, Syria. He completed his residency in pediatrics at MetroHealth Medical Center, Cleveland, and completed two years of fellowship training in neonatology and pediatric intensive care at MetroHealth Medical Center and UH Rainbow Babies & Children’s Hospital. Dr. Haddad joined the UH Rainbow Babies & Children’s Hospital staff in 2000 from Mt. Sinai East Medical Center, Cleveland, where he served as director of pediatric medicine.
He is a Fellow of the American Academy of Pediatrics and a member of the American College of Ethical Physicians. Dr. Haddad has received multiple departmental teaching awards during his years as a UH Rainbow Babies & Children’s faculty member.
Honors and Recognition
Fellow, American Academy of Pediatrics
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Haitham Haddad did not disclose any Outside Relationships with Industry.